Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Auto and Transport Industry News CEAT Limited smashes revenue records in Q2 FY24-25 but faces margin squeeze—What’s next for the tyre giant? In its Q2 FY24-25 financial update, CEAT Limited, a flagship company of the RPG Group, announced a consolidated… byPallavi MadhirajuOctober 18, 2024